Matrigel Basement Membrane Matrix influences expression of microRNAs in cancer cell lines

Biochemical and Biophysical Research Communications

Volumn 427, Issue 2, 2012, Pages 343-348

  Price, Karina J ^a,b   Tsykin, Anna ^c,d   Giles, Keith M ^a   Sladic, Rosemary T ^c   Epis, Michael R ^a   Ganss, Ruth ^a   Goodall, Gregory J ^c,d   Leedman, Peter J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CENTRE FOR CANCER BIOLOGY   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cancer; Cell culture; Matrigel; MicroRNA

Indexed keywords

MATRIGEL; MICRORNA; MICRORNA 1290; MICRORNA 210; MICRORNA 29B; MICRORNA 32; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL PROLIFERATION; COLON CANCER; DOWN REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLLAGEN; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; MICRORNAS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOGLYCANS;

EID: 84867880317     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.059     Document Type: Article

References (49)

1. Kim S.H., Turnbull J., Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol. 2011, 209:139-151.
2. Bissell M.J., Hall H.G., Parry G. How does the extracellular matrix direct gene expression?. J. Theor. Biol. 1982, 99:31-68.
3. Spencer V.A., Xu R., Bissell M.J. Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress. Adv. Cancer Res. 2007, 97:275-294.
4. Elliott T., Sethi T. Integrins and extracellular matrix: a novel mechanism of multidrug resistance. Expert Rev. Anticancer Ther. 2002, 2:449-459.
5. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2002, 2:91-100.
6. Hakkinen K.M., Harunaga J.S., Doyle A.D., et al. Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Eng. Part A 2011, 17:713-724.
7. Benton G., Kleinman H.K., George J., et al. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. Int. J. Cancer 2011, 128:1751-1757.
8. Kleinman H.K., Martin G.R. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 2005, 15:378-386.
9. Fridman R., Giaccone G., Kanemoto T., et al. Reconstituted basement membrane (Matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6698-6702.
10. Harma V., Virtanen J., Makela R., et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 2010, 5:e10431.
11. Kenny P.A., Lee G.Y., Myers C.A., et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol. Oncol. 2007, 1:84-96.
12. Mullen P. The use of Matrigel to facilitate the establishment of human cancer cell lines as xenografts. Methods Mol. Med. 2004, 88:287-292.
13. Lee G.Y., Kenny P.A., Lee E.H., et al. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 2007, 4:359-365.
14. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
15. Brodersen P., Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev. Mol. Cell Biol. 2009, 10:141-148.
16. Witkos T.M., Koscianska E., Krzyzosiak W.J. Practical Aspects of microRNA Target Prediction. Curr. Mol. Med. 2011, 11:93-109.
17. Lewis B.P., Shih I.H., Jones-Rhoades M.W., et al. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
18. Chen J.F., Mandel E.M., Thomson J.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
19. Cheng A.M., Byrom M.W., Shelton J., et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005, 33:1290-1297.
20. Zhang B., Pan X., Cobb G.P., et al. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302:1-12.
21. Thomson J.M., Parker J., Perou C.M., et al. A custom microarray platform for analysis of microRNA gene expression. Nat. Methods 2004, 1:47-53.
22. Yang Y.H., Buckley M.J., Speed T.P. Analysis of cDNA microarray images. Brief. Bioinform. 2001, 2:341-349.
23. Spandidos A., Wang X., Wang H., et al. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010, 38:D792-D799.
24. Krek A., Grun D., Poy M.N., et al. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
25. Enright A.J., John B., Gaul U., et al. MicroRNA targets in Drosophila. Genome Biol. 2003, 5:R1.
26. Smyth G.K. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. Springer, New York. R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber (Eds.).
27. Gentleman R.C., Carey V.J., Bates D.M., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
28. Smyth G.K., Speed T. Normalization of cDNA microarray data. Methods 2003, 31:265-273.
29. Smyth G.K., Michaud J., Scott H.S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 2005, 21:2067-2075.
30. G.K. Smyth, Linear models and empirical bayes methods for assessing differential expression in microarray experiments, Stat. Appl. Genet. Mol. Biol. 3 (2004) Article3.
31. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57:289-300.
32. Devlin C., Greco S., Martelli F., et al. MiR-210: more than a silent player in hypoxia. IUBMB Life 2011, 63:94-100.
33. Rieckmann T., Kotevic I., Trueb B. The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion. Exp. Cell Res. 2008, 314:1071-1081.
34. Tsuchiya S., Fujiwara T., Sato F., et al. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J. Biol. Chem. 2011, 286:420-428.
35. Ying Q., Liang L., Guo W., et al. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 2011, 54:2064-2075.
36. Villarreal G., Oh D.J., Kang M.H., et al. Coordinated regulation of extracellular matrix synthesis by the microRNA-29 family in the trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 2011, 52:3391-3397.
37. Lang N., Liu M., Tang Q.L., et al. Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. Chin. J. Cancer 2010, 29:603-610.
38. Liu Y., Taylor N.E., Lu L., et al. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 2010, 55:974-982.
39. Brakebusch C., Fassler R. Beta 1 integrin function in vivo: adhesion, migration and more. Cancer Metastasis Rev. 2005, 24:403-411.
40. Ambs S., Prueitt R.L., Yi M., et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008, 68:6162-6170.
41. Mascaux C., Laes J.F., Anthoine G., et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur. Respir. J. 2009, 33:352-359.
42. Pichiorri F., Suh S.S., Ladetto M., et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc. Natl. Acad. Sci. USA 2008, 105:12885-12890.
43. Leiss M., Beckmann K., Giros A., et al. The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr. Opin. Cell Biol. 2008, 20:502-507.
44. Camps C., Buffa F.M., Colella S., et al. Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 2008, 14:1340-1348.
45. Fukushima K., Murata M., Hachisuga M., et al. Hypoxia inducible factor 1 alpha regulates Matrigel-induced endovascular differentiation under normoxia in a human extravillous trophoblast cell line. Placenta 2008, 29:324-331.
46. Surazynski A., Donald S.P., Cooper S.K., et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int. J. Cancer 2008, 122:1435-1440.
47. Luna C., Li G., Qiu J., et al. Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 2011, 52:3567-3572.
48. Blenkiron C., Goldstein L.D., Thorne N.P., et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007, 8:R214.
49. Genovesi L.A., Carter K.W., Gottardo N.G., et al. Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. PLoS One 2011, 6:e23935.